Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Not all investors can use a backdoor Roth. This intro clarifies eligibility and the basic implementation steps.
27,669 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
A telecom stock this rose 19% over the past year, but a prominent fund sold out. Discover the drivers behind the move...
AI optimism pushed valuations to lofty highs. This guide explains why stocks wall street says to be cautious about tw...
AppLovin exposes investors to a volatile mix of ad spend cycles and AI disruption fears. This guide breaks down the d...
Discover how to spot cash-flow opportunities in Zillow’s ranked market ripe. This guide breaks down how to evaluate d...
Sabre, a travel-technology stalwart, is navigating a recovering travel market and shifting tech spend. This article b...
As the 2027 Social Security COLA outlook takes shape, retirees want clarity on budget impact. This guide breaks down ...
Nike's profit margins fell as the company faced pricing, demand, and currency headwinds. This guide breaks down the m...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...
A mid-sized fund wrapped up a $9 million exit from a major pawn shop operator after a rally of about 150% over the ye...
Two popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...
A last-minute show cancellation can hit your wallet as hard as your plans. This article breaks down the financial rip...